Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Cardiologist compensation still rising, especially in invasive and interventional cardiology
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
Endoscopies at Vanderbilt exposed patients to HIV, hepatitis C
The exact number of patients potentially infected was not released. However, the botched procedures date back some six months.
NIH awards commercialization grant for wrist-worn continuous ICU-grade blood pressure monitor
Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.
CMS updates Medicare coverage for AI-powered coronary plaque assessments
The new policy goes into effect in November, improving Medicare coverage for a technology that has rapidly gained momentum in recent years.
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Where COVID-19 is hitting state economies the hardest

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

March 31, 2020

CMS eases regulations for COVID-19 response

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

March 31, 2020

HHS accelerates clinical trials for COVID-19 vaccines

HHS is speeding up the development and manufacturing of COVID-19 vaccines by partnering with Johnson & Johnson-owned Janssen Research and Development and Moderna Therapeutics.

March 30, 2020

Humana, Cigna waive out-of-pocket costs for members treated for COVID-19

Humana and Cigna both announced March 30 that consumers would not have to pay for treatment related to COVID-19-covered services.

March 30, 2020

COVID-19 cases cause big losses for hospitals

Hospitals are facing “massive losses” treating patients with COVID-19––even with higher reimbursement for service, according to a new study from Strata Decision.

March 27, 2020

Aetna waives costs for COVID-19 treatment

Health insurer Aetna, owned by CVS Health, has opted to waive cost-sharing and co-pays for commercially insured members of the company when it comes to care for COVID-19.

March 25, 2020

Quarantining infected people, social distancing work to control spread of COVID-19

A new study conducted in a simulated Singapore setting reveals that efforts to contain the spread of the new coronavirus, COVID-19, can actually have a positive effect.

March 24, 2020

Amazon Web Services commits $20M to COVID-19 diagnostic program

Amazon Web Services (AWS) is jumping in to help curb the spread of COVID-19 with a new Diagnostic Development Initiative to support customers working on bringing better, more accurate diagnostic solutions to market.

March 20, 2020

Around the web

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Cardiovascular Business

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Clinical

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Endoscopies at Vanderbilt exposed patients to HIV, hepatitis C

NIH awards commercialization grant for wrist-worn continuous ICU-grade blood pressure monitor

CMS updates Medicare coverage for AI-powered coronary plaque assessments

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

Around the web